Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill

Source: CNBC Top Stories | Published: February 5, 2026, 2:36 pm | Read Original

Neutral 0.0

Novo Nordisk and Eli Lilly fell after Hims & Hers said it will offer a copy of the Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.

Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.

More Like This

Market & Industry Analysis Straight to Your Inbox

Glideslope AI

Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill

Novo Nordisk and Eli Lilly fell after Hims & Hers said it will offer a copy of the Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.

CNBC Top Stories • Feb 5, 2026 • Found on Glideslope.ai

Post hash: t4hve4i • glideslope.ai/post/t4hve4i

Sentiment

Neutral • Score: 0.0

-100 (Bearish) +100 (Bullish)

Fraywire Market Portal, Breaking Metrics Newsletter, and Glideslope AI are designed for informational purposes only. The content provided across these platforms—including, but not limited to, stock and crypto watchlists, price tracking, trade tracking, sentiment analysis, and news articles—should not be construed as financial advice or research reports. Users are encouraged to conduct their own research and consult with qualified financial professionals before making any investment decisions. While we strive to ensure the accuracy, completeness, and reliability of the information provided, Fraywire, Breaking Metrics, and Glideslope AI make no guarantees or warranties regarding the content's validity. By using these platforms, you acknowledge and agree that you are solely responsible for your own investment decisions and actions. Fraywire, Breaking Metrics, and Glideslope AI shall not be held liable for any losses or damages resulting from the use of the information provided.

Get Connected

Fraywire & Glideslope AI are Breaking Metrics productions.
Contact the developer for advertising opportunities, questions, and more at roy@rmahd.com

○ Subscribe
○ Fraywire+
○ Glideslope AI
○ Blog
○ RMAHD
○ Merch!

Pulse AI Analysis

Related Insights

More Like This

Alphabet stock is falling on its CapEx guidance, but this analyst says "it's still a great story"

Stanford Student Reveals Insidious ‘Disability’ Trend Sweeping Nation’s Elite Schools

Why Alphabet’s stock is falling despite booming cloud growth

Hims & Hers launch of compounded $49 Wegovy pill pummels Novo Nordisk’s shares

Boar's Head reopens Virginia deli meat plant tied to deadly listeria outbreak

Bitcoin's monthslong slide continues, hitting fresh 15-month low of $67,000

Market & Industry Analysis Straight to Your Inbox

My Notes